Prevalence and Stratification of Polyvascular Disease in Acute Myocardial Infarction Patients: A Cross-Sectional Study at Mayo Hospital, Lahore: Polyvascular Disease in Acute Myocardial Infarction Patients

Muhammad Afzal Ali; Ayesha Tariq; Muhammad Arslan Aslam; Waseem Ahmed; Ali Saqlain Haider; Asma Sharif

doi:10.54393/pbmj.v7i01.1023

Authors

Muhammad Afzal Ali King Edward Medical University, Lahore, Pakistan
Ayesha Tariq Department of Cardiology, King Edward Medical University, Lahore, Pakistan
Muhammad Arslan Aslam Department of Cardiology, King Edward Medical University, Lahore, Pakistan
Waseem Ahmed Department of Cardiology, King Edward Medical University, Lahore, Pakistan
Ali Saqlain Haider Department of Nephrology, University of Lahore, Lahore, Pakistan
Asma Sharif Department of Cardiology, King Edward Medical University, Lahore, Pakistan

DOI:

https://doi.org/10.54393/pbmj.v7i01.1023

Keywords:

Myocardial Infarction, Polyvascular Disease, Cardiovascular Events

Abstract

Polyvascular Disease, that encompasses peripheral artery disease and cerebrovascular disease, has gained prominence due to expanded clinical focus and research, primarily driven by its association with major adverse cardiovascular events (MACEs) like myocardial infarction, cardiovascular death, and ischemic stroke. Objective: To determine the patients of PVD in patients with acute myocardial infarction (AMI). Methods: A cross-sectional study was designed and conducted at Department of Cardiology, Mayo Hospital, Lahore. between August 3, 2022 and February 2, 2023. 183 patients with AMI of either gender, age above 25 years and up to 80 years were included. Data were analyzed statistically using SPSS version 25.0. Results: Our study reported PVD in 57.4% of the patients with AMI. According to the stratification of PVD with numerous variables, notable variations emerged concerning age and symptom duration (p<0.05), whereas gender, BMI, type of AMI, and socio-economic status showed insignificant differences. Conclusions: Our findings demonstrated that the PVD was highly prevalent among patients with AMI.

References

Chen XH, Jiang HL, Li YM, Chan CP, Mo JR, Tian CW rt al. Prognostic values of 4 risk scores in Chinese patients with chest pain: prospective 2-centre cohort study. Medicine. 2016 Dec; 95(52). doi: 10.1097/MD.0000000000004778. DOI: https://doi.org/10.1097/MD.0000000000004778

Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M rt al. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation. 2015 Jan; 131(4): e29-322.

Hageman SH, McKay AJ, Ueda P, Gunn LH, Jernberg T, Hagström E rt al. Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm. European Heart Journal. 2022 May; 43(18): 1715-27. doi: 10.1093/eurheartj/ehac056. DOI: https://doi.org/10.1093/eurheartj/ehac056

Conte SM and Vale PR. Peripheral arterial disease. Heart, Lung and Circulation. 2018 Apr; 27(4): 427-32. doi: 10.1016/j.hlc.2017.10.014. DOI: https://doi.org/10.1016/j.hlc.2017.10.014

Mizzi A, Cassar K, Bowen C, Formosa C. The progression rate of peripheral arterial disease in patients with intermittent claudication: a systematic review. Journal of Foot and Ankle Research. 2019 Dec; 12: 1-9. doi: 10.1186/s13047-019-0351-0. DOI: https://doi.org/10.1186/s13047-019-0351-0

Faxon DP, Fuster V, Libby P, Beckman JA, Hiatt WR, Thompson RW rt al. Atherosclerotic vascular disease conference: writing group III: pathophysiology. Circulation. 2004 Jun; 109(21): 2617-25. doi: 10.1161/01.CIR.0000128520.37674.EF. DOI: https://doi.org/10.1161/01.CIR.0000128520.37674.EF

Rehring TF, Sandhoff BG, Stolcpart RS, Merenich JA, Hollis Jr HW. Atherosclerotic risk factor control in patients with peripheral arterial disease. Journal of Vascular Surgery. 2005 May; 41(5): 816-22. doi: 10.1016/j.jvs.2005.01.047. DOI: https://doi.org/10.1016/j.jvs.2005.01.047

Gresele P, Guglielmini G, Del Pinto M, Calabro P, Pignatelli P, Patti G, rt al. Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry. International Journal of Cardiology. 2021 Mar; 327: 176-82. doi: 10.1016/j.ijcard.2020.10.079. DOI: https://doi.org/10.1016/j.ijcard.2020.10.079

Jukema JW, Szarek M, Zijlstra LE, de Silva HA, Bhatt DL, Bittner VA rt al. ODYSSEY OUTCOMES Committees and Investigators. Alirocumab in patients with PVD and recent acute coronary syndrome: ODYSSEY OUTCOMES trial. Journal of American College of Cardiology. 2019 Sep; 74(9): 1167-76.

Ishihara T, Yamaji K, Iida O, Kohsaka S, Inohara T, Shinke T rt al. Impact of peripheral artery disease on short-term outcomes after percutaneous coronary intervention: A report from Japanese nationwide registry. PloS One. 2020 Oct; 15(10): e0240095. doi: 10.1371/journal.pone.0240095. DOI: https://doi.org/10.1371/journal.pone.0240095

Subherwal S, Bhatt DL, Li S, Wang TY, Thomas L, Alexander KP rt al. PVD and long-term cardiovascular outcomes in older patients with non–ST-segment–elevation myocardial infarction. Circulation: Cardiovascular Quality and Outcomes. 2012 Jul; 5(4): 541-9. doi: 10.1161/CIRCOUTCOMES.111.964379. DOI: https://doi.org/10.1161/CIRCOUTCOMES.111.964379

Al Thani H, El-Menyar A, AlHabib KF, Al-Motarreb A, Hersi A, AlFaleh H rt al. PVD in patients presenting with acute coronary syndrome: its predictors and outcomes. The Scientific World Journal. 2012 Jan; 2012. doi: 10.1100/2012/284851. DOI: https://doi.org/10.1100/2012/284851

Bhatt DL, Peterson ED, Harrington RA, Ou FS, Cannon CP, Gibson CM rt al. Prior PVD: risk factor for adverse ischaemic outcomes in acute coronary syndromes. European Heart Journal. 2009 May; 30(10): 1195-202. doi: 10.1093/eurheartj/ehp099. DOI: https://doi.org/10.1093/eurheartj/ehp099

Jönelid B, Johnston N, Berglund L, Andrén B, Kragsterman B, Christersson C. Ankle brachial index most important to identify PVD in patients with non-ST elevation or ST-elevation myocardial infarction. European Journal of Internal Medicine. 2016 May; 30: 55-60. doi: 10.1016/j.ejim.2015.12.016. DOI: https://doi.org/10.1016/j.ejim.2015.12.016

World Health Organization. Sample Size Calculator. [Last cited: 10th Jan 2024]. Available at: https://cdn.who.int/media/docs/default-source/ncds/ncd-surveillance/steps/sample-size-calculator.xls

Vidakovic R, Schouten O, Kuiper R, Hoeks SE, Flu WJ, van Kuijk JP rt al. The prevalence of PVD in patients referred for peripheral arterial disease. European Journal of Vascular and Endovascular Surgery. 2009 Oct; 38(4): 435-40. doi: 10.1016/j.ejvs.2009.05.006. DOI: https://doi.org/10.1016/j.ejvs.2009.05.006

Fowkes FG, Low LP, Tuta S, Kozak J. Ankle-brachial index and extent of atherothrombosis in 8891 patients with or at risk of vascular disease: results of the international AGATHA study. European Heart Journal. 2006 Aug; 27(15): 1861-7. doi: 10.1093/eurheartj/ehl114. DOI: https://doi.org/10.1093/eurheartj/ehl114

Suárez C, Zeymer U, Limbourg T, Baumgartner I, Cacoub P, Poldermans D rt al. Influence of PVD on cardiovascular event rates. Insights from the REACH Registry. Vascular Medicine. 2010 Aug; 15(4): 259-65. doi: 10.1177/1358863X10373299. DOI: https://doi.org/10.1177/1358863X10373299

Vora AN, Wang TY, Hellkamp AS, Thomas L, Henry TD, Goyal A rt al. Differences in short-and long-term outcomes among older patients with ST-elevation versus non–ST-elevation myocardial infarction with angiographically proven coronary artery disease. Circulation: Cardiovascular Quality and Outcomes. 2016 Sep; 9(5): 513-22. doi: 10.1161/CIRCOUTCOMES.115.002312. DOI: https://doi.org/10.1161/CIRCOUTCOMES.115.002312

Miura T, Soga Y, Doijiri T, Aihara H, Yokoi H, Iwabuchi M rt al. Prevalence and clinical outcome of polyvascular atherosclerotic disease in patients undergoing coronary intervention. Circulation Journal. 2013; 77(1): 89-95. doi: 10.1253/circj.CJ-12-0535. DOI: https://doi.org/10.1253/circj.CJ-12-0535

Collet JP, Cayla G, Ennezat PV, Leclercq F, Cuisset T, Elhadad S rt al. Systematic detection of PVD combined with aggressive secondary prevention in patients presenting with severe coronary artery disease: The randomized AMERICA Study. International Journal of Cardiology. 2018 Mar; 254: 36-42. doi: 10.1016/j.ijcard.2017.11.081. DOI: https://doi.org/10.1016/j.ijcard.2017.11.081

Mukherjee D, Eagle KA, Kline-Rogers E, Feldman LJ, Juliard JM, Agnelli G rt al. Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the Global Registry of Acute Coronary Events). The American Journal of Cardiology. 2007 Jul; 100(1): 1-6. doi: 10.1016/j.amjcard.2007.02.046. DOI: https://doi.org/10.1016/j.amjcard.2007.02.046

Ferreira-González I, Miralda GP, Heras M, Ribera A, Marsal JR, Cascant P rt al. Prognosis and management of patients with acute coronary syndrome and PVD. Revista Española de Cardiología (English Edition). 2009 Sep; 62(9): 1012-21. doi: 10.1016/S1885-5857(09)73267-0. DOI: https://doi.org/10.1016/S1885-5857(09)73267-0

Meizels A, Zeitoun DM, Bataille V, Cambou JP, Collet JP, Cottin Y rt al. Impact of PVD on baseline characteristics, management and mortality in AMI. The Alliance project. Archives of Cardiovascular Diseases. 2010 Apr; 103(4): 207-14. doi: 10.1016/j.acvd.2010.02.002. DOI: https://doi.org/10.1016/j.acvd.2010.02.002

Aboyans V, Ricco JB, Bartelink ML, Björck M, Brodmann M, Cohner T rt al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Kardiologia Polska (Polish Heart Journal). 2017; 75(11): 1065-160. doi: 10.5603/KP.2017.0216 DOI: https://doi.org/10.5603/KP.2017.0216

Musiałek P and Grunwald IQ. How asymptomatic is" asymptomatic" carotid stenosis?: Resolving fundamental confusion (s)-and confusions yet to be resolved. Polish Archives of Internal Medicine. 2017 Nov; 127(11): 718-9. doi: 10.20452/pamw.4157. DOI: https://doi.org/10.20452/pamw.4157